Financials

  • Market Capitalization 214.49 M
  • Employee 95
  • Founded N/A
  • CEO Daniel Vitt
  • Website www.imux.com
  • Headquarter Delaware, United States
  • FIGI BBG001M75SX4
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-4.34
ratio cours/chiffre d'affaires

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
3556
GLSI
Greenwich LifeSciences, Inc. - Common stock
14.79 USD-1.07%-17.14%+9.56%+27.50%217.09 M USD
3559
NERV
Minerva Neurosciences, Inc - Common Stock
4.49 USD-1.54%-6.65%+13.67%+91.06%214.39 M USD
3574
VYGR
Voyager Therapeutics, Inc. - Common Stock
3.36 USD-2.61%-4.55%+7.69%-27.74%207.04 M USD
3577
CRBP
Corbus Pharmaceuticals Holdings, Inc. - Common Stock
10.64 USD-2.47%-3.18%+18.09%-35.90%205.79 M USD

Nouvelles